VaxCell Biotherapeutics Co., Ltd.

The Better life with Anti-cancer immunotherapy

Add To Watchlist
General Information
Company Name
VaxCell Biotherapeutics Co., Ltd.
Founded Year
2010
Location (Offices)
Korea South +1
Founders / Decision Makers
Number of Employees
7
Industries
Biopharma, Biotechnology, Health Care +1
Funding Stage
Post Ipo Equity
Social Media

VaxCell Biotherapeutics Co., Ltd. - Company Profile

VaxCell Biotherapeutics Co., Ltd. is a biopharmaceutical startup grounded in the vision of creating a better life through anti-cancer immunotherapy. With a focus on leading the global NK anti-cancer immune cell therapy, the company aims to commercialize advanced medical technology, extending survival and improving the quality of life for patients. Through its innovative technology and commitment to social responsibility, VaxCell Biotherapeutics Co., Ltd. has garnered the trust of investors such as DAYLI Partners and HB Investment, receiving a post-IPO equity investment on 01 January 2021. Founded in 2010 and headquartered in South Korea, the company aspires to become a best-in-class biotech firm, with a strong focus on innovation, talent, and respect for life.

Taxonomy: Pharmaceuticals, Immunotherapy, Cancer Treatment, Cellular Therapy, Medical Technology, Innovation, Clinical Research, NK Cells, CAR-T Cell Therapy, Cell Therapy, Biotherapeutics, Clinical Trials, Research & Development

Funding Rounds & Investors of VaxCell Biotherapeutics Co., Ltd. (1)

View All
Funding Stage Amount No. Investors Investors Date
Post-IPO Equity Unknown 2
DAYLI Partners, investor in VaxCell Biotherapeutics Co., Ltd.'s Post-IPO Equity round HB Investment, investor in VaxCell Biotherapeutics Co., Ltd.'s Post-IPO Equity round
01 Jan 2021

Latest News of VaxCell Biotherapeutics Co., Ltd.

View All

No recent news or press coverage available for VaxCell Biotherapeutics Co., Ltd..

Similar Companies to VaxCell Biotherapeutics Co., Ltd.

View All
KaliVir Immunotherapeutics - Similar company to VaxCell Biotherapeutics Co., Ltd.
KaliVir Immunotherapeutics KaliVir Immunotherapeutics was founded in 2019 to pioneer a unique and novel approach to cancer treatment.
Denvax - Similar company to VaxCell Biotherapeutics Co., Ltd.
Denvax Denvax, spearheaded by Dr. Sharmin Yaqin & Dr. Jamal A Khan, offers a personalized cancer treatment using Immunotherapy.
EnGeneIC - Similar company to VaxCell Biotherapeutics Co., Ltd.
EnGeneIC First-in-class cyto-immunotherapy platform targeting the tumour directly and leveraging the patient's immune system
Tolerx, Inc. - Similar company to VaxCell Biotherapeutics Co., Ltd.
Tolerx, Inc.
OSE Immunotherapeutics - Similar company to VaxCell Biotherapeutics Co., Ltd.
OSE Immunotherapeutics Immuno-Oncology and Immuno-Inflammation - Breakthrough Immuno-Science for Patients
Circle Decoration Circle Decoration

Want to dive deeper into VaxCell Biotherapeutics Co., Ltd.? Join now to access exclusive insights and find similar companies like this — powered by AI analytics.

Register Now